Skip to main content
Top
Published in: BMC Infectious Diseases 1/2016

Open Access 01-12-2016 | Case report

First case report of infection due to Cupriavidus gilardii in a patient without immunodeficiency: a case report

Authors: Takehito Kobayashi, Itaru Nakamura, Hiroaki Fujita, Ayaka Tsukimori, Akihiro Sato, Shinji Fukushima, Kiyofumi Ohkusu, Tetsuya Matsumoto

Published in: BMC Infectious Diseases | Issue 1/2016

Login to get access

Abstract

Background

Cupriavidus gilardii is an aerobic, Gram-negative, glucose-nonfermenting rod that was first identified in 1999. Because of the difficulty in accurate species identification of C. gilardii, there are few case reports of infection caused by this organism. In previous reports, C. gilardii has been characterized as an organism with low pathogenicity that causes opportunistic infections.

Case presentation

We encountered a case of pacemaker-associated bloodstream infection caused by C. gilardii in a 90-year old woman without obvious immunodeficiency. We identified the isolates as C. gilardii by sequencing of the 16S rRNA gene. The patient was treated with removal of the lead and administration of antimicrobial agents. Because of the acquisition of antibiotic resistance during antibiotic treatment, the antimicrobial agent was changed during the course of treatment.

Conclusions

To our knowledge, this is the first report of an infection caused by this organism in a patient without obvious immunodeficiency. Although the true pathogenicity of C. gilardii is unclear, the possibility that it exerts pathogenicity not only in persons with immunodeficiency but also in immunocompetent persons is suggested.
Literature
1.
go back to reference Coenye T, Falsen E, Vancanneyt M, Hoste B, Govan JR, Kersters K, Vandamme P. Classification of Alcaligenes faecalis-like isolates from the environment and human clinical samples as Ralstonia gilardii sp. nov. Int J Syst Bacteriol. 1999;49(Pt 2):405–13.CrossRefPubMed Coenye T, Falsen E, Vancanneyt M, Hoste B, Govan JR, Kersters K, Vandamme P. Classification of Alcaligenes faecalis-like isolates from the environment and human clinical samples as Ralstonia gilardii sp. nov. Int J Syst Bacteriol. 1999;49(Pt 2):405–13.CrossRefPubMed
2.
go back to reference Vandamme P, Coenye T. Taxonomy of the genus Cupriavidus: a tale of lost and found. Int J Syst Evol Microbiol. 2004;54(Pt 6):2285–9.CrossRefPubMed Vandamme P, Coenye T. Taxonomy of the genus Cupriavidus: a tale of lost and found. Int J Syst Evol Microbiol. 2004;54(Pt 6):2285–9.CrossRefPubMed
3.
go back to reference Coenye T, Vandamme P, LiPuma JJ. Infection by Ralstonia species in cystic fibrosis patients: identification of R. pickettii and R. mannitolilytica by polymerase chain reaction. Emerg Infect Dis. 2002;8(7):692–6.CrossRefPubMedPubMedCentral Coenye T, Vandamme P, LiPuma JJ. Infection by Ralstonia species in cystic fibrosis patients: identification of R. pickettii and R. mannitolilytica by polymerase chain reaction. Emerg Infect Dis. 2002;8(7):692–6.CrossRefPubMedPubMedCentral
4.
go back to reference Vandamme P, Goris J, Coenye T, Hoste B, Janssens D, Kersters K, De Vos P, Falsen E. Assignment of Centers for Disease Control group IVc-2 to the genus Ralstonia as Ralstonia paucula sp. nov. Int J Syst Bacteriol. 1999;49(Pt 2):663–9.CrossRefPubMed Vandamme P, Goris J, Coenye T, Hoste B, Janssens D, Kersters K, De Vos P, Falsen E. Assignment of Centers for Disease Control group IVc-2 to the genus Ralstonia as Ralstonia paucula sp. nov. Int J Syst Bacteriol. 1999;49(Pt 2):663–9.CrossRefPubMed
5.
go back to reference Wauters G, Claeys G, Verschraegen G, De Baere T, Vandecruys E, Van Simaey L, De Ganck C, Vaneechoutte M. Case of catheter sepsis with Ralstonia gilardii in a child with acute lymphoblastic leukemia. J Clin Microbiol. 2001;39(12):4583–4.CrossRefPubMedPubMedCentral Wauters G, Claeys G, Verschraegen G, De Baere T, Vandecruys E, Van Simaey L, De Ganck C, Vaneechoutte M. Case of catheter sepsis with Ralstonia gilardii in a child with acute lymphoblastic leukemia. J Clin Microbiol. 2001;39(12):4583–4.CrossRefPubMedPubMedCentral
6.
go back to reference Karafin M, Romagnoli M, Fink DL, Howard T, Rau R, Milstone AM, Carroll KC. Fatal infection caused by Cupriavidus gilardii in a child with aplastic anemia. J Clin Microbiol. 2010;48(3):1005–7.CrossRefPubMedPubMedCentral Karafin M, Romagnoli M, Fink DL, Howard T, Rau R, Milstone AM, Carroll KC. Fatal infection caused by Cupriavidus gilardii in a child with aplastic anemia. J Clin Microbiol. 2010;48(3):1005–7.CrossRefPubMedPubMedCentral
7.
go back to reference Tena D, Losa C, Medina MJ, Sáez-Nieto JA. Muscular abscess caused by Cupriavidus gilardii in a renal transplant recipient. Diagn Microbiol Infect Dis. 2014;79(1):108–10.CrossRefPubMed Tena D, Losa C, Medina MJ, Sáez-Nieto JA. Muscular abscess caused by Cupriavidus gilardii in a renal transplant recipient. Diagn Microbiol Infect Dis. 2014;79(1):108–10.CrossRefPubMed
8.
go back to reference CLSI. Performance standards for antimicrobial susceptibility testing, 26th informational supplement. M100-S26. Wayne: Clinical and Laboratory Standards Institute; 2016. CLSI. Performance standards for antimicrobial susceptibility testing, 26th informational supplement. M100-S26. Wayne: Clinical and Laboratory Standards Institute; 2016.
9.
go back to reference Masaki T, Ohkusu K, Ezaki T, Miyamoto H. Nocardia elegans infection involving purulent arthritis in humans. J Infect Chemother. 2012;18(3):386–9.CrossRefPubMed Masaki T, Ohkusu K, Ezaki T, Miyamoto H. Nocardia elegans infection involving purulent arthritis in humans. J Infect Chemother. 2012;18(3):386–9.CrossRefPubMed
Metadata
Title
First case report of infection due to Cupriavidus gilardii in a patient without immunodeficiency: a case report
Authors
Takehito Kobayashi
Itaru Nakamura
Hiroaki Fujita
Ayaka Tsukimori
Akihiro Sato
Shinji Fukushima
Kiyofumi Ohkusu
Tetsuya Matsumoto
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2016
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-016-1838-y

Other articles of this Issue 1/2016

BMC Infectious Diseases 1/2016 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.